ALX ONCOLOGY HOLDINGS INC Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Alx Oncology Holdings Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Alx Oncology Holdings Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $6.95M, a 0.17% decline year-over-year.
  • Alx Oncology Holdings Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $28M, a 8.16% increase year-over-year.
  • Alx Oncology Holdings Inc annual Share-based Payment Arrangement, Expense for 2023 was $26.3M, a 10.2% increase from 2022.
  • Alx Oncology Holdings Inc annual Share-based Payment Arrangement, Expense for 2022 was $23.8M, a 71.3% increase from 2021.
  • Alx Oncology Holdings Inc annual Share-based Payment Arrangement, Expense for 2021 was $13.9M, a 156% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.